跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
DBL EPHEDRINE SULFATE 30mg/1mL Injection - TGA Drug Approval Details
Approvals
/
TGA
/
DBL EPHEDRINE SULFATE 30mg/1mL Injection
Approved
STANDARD
DBL EPHEDRINE SULFATE 30mg/1mL Injection
Pfizer Australia Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
May 30, 2025
Approval ID
9c507b63e054890e
Company
Pfizer Australia Pty Ltd
Type
Standard
Approval Details
Approval Id
9c507b63e054890e
Product Name
DBL EPHEDRINE SULFATE 30mg/1mL Injection
Artg Id
16325
Artg Name
DBL EPHEDRINE SULFATE 30mg/1mL injection ampoule
Sponsor
Pfizer Australia Pty Ltd
Company Detail Path
/organization/pfizer-australia-pty-ltd
Artg Date
1991-10-08
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Consumer Medicine Info
https://medical-cdn.nocode.com/drug_tga/c8b4d914cb057a1fa423ea0c2b74667c.pdf
Product Information
https://medical-cdn.nocode.com/drug_tga/f0551a9653ee93a07bf157372aff8c82.pdf
Active Ingredients
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
May 30, 2025
Approval ID
9c507b63e054890e
Type
Standard
Back to TGA Approvals